Screening compound: C16H19ClFN3O3 (S254-0850)

Screening compound: C<sub>16</sub>H<sub>19</sub>ClFN<sub>3</sub>O<sub>3</sub> (S254-0850)
Screening compound: C<sub>16</sub>H<sub>19</sub>ClFN<sub>3</sub>O<sub>3</sub> (S254-0850) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C16H19ClFN3O3 (S254-0850)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S254-0850

Molecular Formula

C16H19ClFN3O3 (C16 H19 ClFN3 O3)

Compound Name

N-(3-chlorophenyl)-4-fluoro-2-(morpholine-4-carbonyl)pyrrolidine-1-carboxamide

IUPAC name

(2R4R)-N-(3-chlorophenyl)-4-fluoro-2-(morpholine-4-carbonyl)pyrrolidine-1-carboxamide

SMILES

O=C([C@@H](C[C@H](C1)F)N1C(Nc1cccc(Cl)c1)=O)N1CCOCC1

InChI

InChI=1S/C16H19ClFN3O3/c17-11-2-1-3-13(8-11)19-16(23)21-10-12(18)9-14(21)15(22)20-4-6-24-7-5-20/h1-3,8,12,14H,4-7,9-10H2,(H,19,23)/t12-,14+/m0/s1

InChI Key

IAWWGJZJYSCXDJ-GXTWGEPZSA-N

MDL Number (MFCD)

C16H19ClFN3O3 (S254-0850) in Drug Discovery

Included in Screening Libraries

Bcl2-PPI Inhibitors Library (12246 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS MPO Library (28609 compounds)

Ligand-Gated Ion Channels Library (3887 compounds)

Natural-Product-Based Library (3730 compounds)

PI3K-Targeted Library (17255 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Nervous system
  • Nervous system
  • Eye
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Targets:
  • Ion Channels
  • Kinases
Structure:
  • Pool
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with C16H19ClFN3O3 (S254-0850) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C16H19ClFN3O3 (S254-0850)?
Check Price and Availability of C16H19ClFN3O3 (S254-0850), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C16H19ClFN3O3 (S254-0850) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C16H19ClFN3O3 (S254-0850)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C16H19ClFN3O3 (S254-0850)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C16H19ClFN3O3 (S254-0850) available by request